Call for Abstract
Scientific Program
15th Annual Conference on Stem Cell and Regenerative Medicine, will be organized around the theme “”
STEMGEN 2022 is comprised of 20 tracks and 4 sessions designed to offer comprehensive sessions that address current issues in STEMGEN 2022.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Gene therapy is defined as the transfer of genetic material, typically in the form of a carrier or vector, and the uptake of the gene into the proper cells of the body. Cell therapy is defined introduction of cells with the proper function into a patient. In certain programs both gene therapy and cell treatment.
- Track 1-1somatic gene therapy
- Track 1-2renatal gene therapy
- Track 1-3TCR Therapy
- Track 1-4CAR T cell Therapy
Stem cell treatment, also known as regenerative medicine, involves employing stem cells or their products to stimulate the repair of sick, dysfunctional, or wounded tissue. It is the next step in organ transplantation, replacing donor organs with cells, which are in short supply. Stem cell are undifferentiated cells found in the embryonic, foetal, and adult phases of life that give rise to differentiated cells that form tissue and organ.
- Track 2-1Unipotent stem cell
- Track 2-2multipotent stem cell
- Track 2-3Pluripotent stem cell
- Track 2-4Totipotent stem cell
Three-dimensional cell culture is an artificially constructed environment in which biological cells are allowed to grow and interact in all three dimensions. In contrast to 2D environments, 3D cell culture permits cells to grow in all directions in vitro, much as they would in vivo. Cell culture has numerous advantages in the field of biomaterials. It is simple to control and monitor the environment in order to study cell responses to biomaterials and cell–biomaterial interactions. It also eliminates the necessity for animal testing at different phases of biomaterial development.
- Track 3-1Autologous cells
- Track 3-2Allogenic cells
- Track 3-3Reparative cells
- Track 3-4Bio reactive molecules
Modern health care and laboratory diagnostics rely heavily on biomedicine. It encompasses a wide range of scientific and technological approaches, ranging from in vitro diagnostics to in vitro fertilization, from cystic fibrosis molecular mechanisms to HIV virus population dynamics, from molecular interactions to carcinogenesis research, and from a single-nucleotide polymorphism (SNP) to gene therapy.
- Track 4-1Molecular biology
- Track 4-2Vitro fertilization
Clinical preliminaries are research concentrates on that as cist specialists with deciding if a quality treatment approach is ok for individuals. Foundational microorganism treatment is the utilization of undifferentiated cells to treat or forestall an infection or condition. This normally appears bone marrow transplantation, however the cells can likewise be gotten from umbilical string blood. Research is in progress to foster different hotspots for undifferentiated organisms as well as to apply undeveloped cell medicines for neurodegenerative sicknesses. Undifferentiated cells from the patient are modified by quality treatment in culture to communicate the applicable useful protein.
- Track 5-1Bone-marrow
- Track 5-2Neurodegenerative
- Track 5-3Undeveloped cell medicine
Cell recovery is the science where the strategy of restoration, recovery and improvement that makes genomes, cells, residing creatures and organic systems. Organ recovery is the method involved with embedding or coordinating man-made material into a human to supplant normal organs or tissues. Its motivation is to reestablish a particular capacity or gathering of related capacities, so the patient might get back to a typical life.
- Track 6-1Genomes
- Track 6-2Organic
- Track 6-3system Embedding
Undifferentiated organisms are at the front of one of the most entrancing and progressive areas of medication today. Specialists perceive that undifferentiated organisms can possibly assist with treating various sicknesses by creating sound new cells and tissue. There are a wide scope of sicknesses that are treatable with foundational microorganisms gotten from rope blood and different wellsprings of comparable kind of undifferentiated organisms Hematopoiesis Undifferentiated organism like bone marrow and fringe blood, including undeveloped cell issues, intense and constant types of leukemia ,myeloproliferative problems, and some more.
- Track 7-1Solid Tumors Malignancies
- Track 7-2Leukemia
- Track 7-3Anemia
- Track 7-4Blood Disorders
Regenerative medication might be characterized as the method involved with supplanting or "recovering" human cells, tissues or organs to reestablish or lay out typical capacity. In the event that you have coronary illness, these lab-made heart muscle cells might be utilized as relocated tissue to help fix or supplant harmed heart cells. Cooperating, these activities do great work of easing torment that undeveloped cells and platelets as platelet-rich plasma (PRP) might be utilized.
- Track 8-1Platelet-rich plasma
- Track 8-2Muscle cells
- Track 8-3Heart cells
Implanted scaffolds with inductive niches can facilitate the recruitment and differentiation of host cells, thereby enhancing endogenous tissue regeneration. Extracellular matrix scaffolds derived from cultured cells or natural tissues exhibit superior biocompatibility and trigger favorable immune responses. Scaffolds are three-dimensional porous solid biomaterials designed which. Provide a spatially correct position of cell location Promote cell-biomaterial interactions, cell adhesion, and ECM deposition
- Track 9-1Fibrous tissue
- Track 9-2Porous tissue
- Track 9-3Hydrogel scaffolds
Cancer cells found in tumors or hematological cancers have features similar to normal stem cells, such as the ability to generate all cell types seen in a given cancer sample. CSCs are thus tumorigenic (cancer-forming), maybe in contrast to other cancer cells that are not tumorigenic. Because CSCs make up such a small percentage of the tumor, medications that target the stem cells may not be chosen. Conventional chemotherapy, according to this view, kill differentiated or differentiating cells, which make up the bulk of the tumor but do not create new cells.
- Track 10-1Colon
- Track 10-2Pancreas
- Track 10-3Lung, prostate
- Track 10-4Melanoma
Undeveloped immature microorganisms Embryonic Stem Cell (ESCs) are pluripotent undifferentiated organisms gotten from the inward cell mass of a blastocyst, a beginning phase pre-implantation embryo. Human undeveloped organisms arrive at the blastocyst stage 4-5 days post treatment, when they comprise of 50-150 cells. Undeveloped immature microorganisms of the inward cell mass are pluripotent, meaning they can separate to produce crude ectoderm.
- Track 11-1Pluripotency
- Track 11-2Primitive ectoderm
- Track 11-3Endoderm
- Track 11-4Mesoderm
Atomic Imaging for Following Undeveloped cell Treatment in Cardiovascular disease research. This large number of imaging advances including BLI, FMI, PET, SPECT, and X-ray have been utilized in following foundational microorganism treatment in cardiovascular, which will advance the improvement of undifferentiated organism treatment. Presently, progress in the field of undifferentiated cells is exceptionally encouraging with reports of clinical outcome in dealing with different illnesses like; neurodegenerative sicknesses and macular degeneration advancing quickly.
- Track 12-1Cardiovascular
- Track 12-2Neurodegenerative
- Track 12-3Macular degeneration
In science, recovery is the course of reestablishment, reclamation, and tissue development that makes genomes, cells, living beings, and environments versatile to regular variances or occasions that cause aggravation or harm. Each specie is fit for recovery, from microorganisms to people. Recovery can either be finished where the new tissue is equivalent to the lost tissue, or in complete where after the necrotic tissue comes fibrosis.
- Track 13-1Microorganisms
- Track 13-2Necrotic tissue
- Track 13-3Genomes
- Track 13-4Fibrosis
The outer muscle recovery research group in the Middle for Regenerative Medication fills in as a helpful pipeline from biomedical revelation to clinical execution, further developing therapies for patients with states of the muscles, ligaments, meniscus and bone musculoskeletal repair.
- Track 14-1Bone growth
- Track 14-2Stem cell therapy
- Track 14-3Whole-body biomechanics
- Track 14-4Tissue recycling
3D bio printing is an innovation where bio inks, blended in with by resident cells, are imprinted in 3D to develop regular tissue-like three-layered structures. At present, this innovation can be utilized in different examination regions, for example, tissue designing and new medication improvement. Organ printing uses methods like customary 3D printing where a PC model is taken care of into a printer that sets down progressive layers of plastics.
- Track 15-1Tissue Resident memory cells
- Track 15-2Cellular material
- Track 15-3Selective laser sintering
3D bio printing is an innovation where bio inks, blended in with by resident cells,are imprinted in 3D to develop regular tissue-like three-layered structures. At present, this innovation can be utilized in different examination regions, for example, tissue designing and new medication improvement. Organ printing uses methods like customary 3D printing where a PC model is taken care of into a printer that sets down progressive layers of plastics.
- Track 16-1Stents and grafts
- Track 16-2Artificial joints
- Track 16-3Ligaments and tendons
Tissue can be used to diagnose and classify diseases, such as cancer cell to determine whether or not a patient has cancer, as well as the type of cancer and its characteristics. Tissue engineering is distinguished by its ability to regenerate a patient's own tissues and organs that are completely free of poor bio compatibility limited bio functioning and severe immune rejection. Tissue engineering is frequently regarded as the ultimate medical treatment because to its numerous advantages.
- Track 17-1Muscular tissue
- Track 17-2Connective tissue
- Track 17-3Epithelial tissue
- Track 17-4Nerve tissue
Increasingly complex synthetic tissues serving as in vitro models of human disease will be used to support research on disease mechanisms. Biomedical research relies heavily on small-animal models. Organ typic models, which have been developed for a range of tissues such as the skin, liver, stomach, kidney, and lung, have a realistic micro-anatomy, imitate organ function, and provide insight into cell-to-cell interactions.
- Track 18-1micro-anatomy
- Track 18-2mimic organ function
- Track 18-3cell-to-cell interactions
Increasingly complex synthetic tissues serving as in vitro models of human disease will be used to support research on disease mechanisms. Biomedical research relies heavily on small-animal models. Organ typic models, which have been developed for a range of tissues such as the skin, liver, stomach, kidney, and lung, have a realistic micro-anatomy, imitate organ function, and provide insight into cell-to-cell interactions.
- Track 19-1Stem cell
- Track 19-2Embryonic stem cell
- Track 19-3Epigenetics
As stem cells age, their renewal ability deteriorates and their ability to differentiate into the various cell types is altered. Accordingly, it is suggested aging-induced deterioration of stem cell functions may play a key role in the pathophysiology of the various aging-associated disorders. The stem cell theory of aging postulates that the aging process is the result of the inability of various types of stem cells to continue to replenish the tissues of an organism with functional differentiated cells capable of maintaining that tissues or organs original function.
- Track 20-1Secondary aging
- Track 20-2Maladaptive aging
- Track 20-3Assisted death
- Track 20-4Senemorphic aging